Yinghua Ji

机构：Guilin Medical University, First Affiliated Hospital of Xinxiang Medical University, First Affiliated Hospital of Xi'an Jiaotong University, Anyang Tumor Hospital, Henan Medical University · ORCID：0000-0003-4705-0542

发表论文 169 篇 · 总被引 2782 次 · h-index 25

代表论文

• A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial (2025 · Nature Medicine · 被引 88)
• First‐line serplulimab plus chemotherapy in extensive‐stage small‐cell lung cancer: Updated results and biomarker analysis from the ASTRUM‐005 randomized clinical trial (2025 · 癌症：英文版 · 被引 21)
• A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial (2025 · Nature Medicine · 被引 19)
• Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial (2025 · The Lancet Respiratory Medicine · 被引 13)
• Efficacy and safety of MHB088C, a novel B7-H3-targeted ADC, in patients with relapsed extensive-stage small cell lung cancer (ES-SCLC): Subgroup analysis from a phase 1/2 multicenter study. (2025 · Journal of Clinical Oncology · 被引 6)
• The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes (2025 · Frontiers in Oncology · 被引 6)